PIK3CA Antikörper (Internal Region)
-
- Target Alle PIK3CA Antikörper anzeigen
- PIK3CA (Phosphoinositide-3-Kinase, Catalytic, alpha Polypeptide (PIK3CA))
-
Bindungsspezifität
- Internal Region
-
Reaktivität
- Human
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser PIK3CA Antikörper ist unkonjugiert
-
Applikation
- Immunohistochemistry (IHC), ELISA
- Verwendungszweck
- PIK3CA / P110alpha
- Sequenz
- HQWLKDKNKG EIYD
- Kreuzreaktivität
- Rind (Kuh), Hund, Human, Maus, Ratte
- Aufreinigung
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
- Güteklasse
- Verified
- Immunogen
- Peptide with sequence C-HQWLKDKNKGEIYD, from the internal region of the protein sequence according to NP_006209.2.
- Isotyp
- IgG
- Top Product
- Discover our top product PIK3CA Primärantikörper
-
-
- Applikationshinweise
-
Immunohistochemistry: In paraffin embedded Human Brain (Cerebral Cortex) shows cytoplasm stained in the cell bodies. Recommended concentration: 2-3 μg/mL. Paraffin embedded Human Heart. Recommended concentration: 5 μg/mL. This antibody has been successfull
Western Blot: Preliminary experiments in lysates of cell lines A431, HeLa and Jurkat gave no specific signal but low background (at antibody concentration up to 1 μg/mL).
Peptide ELISA: antibody detection limit dilution 1:128000.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5 mg/mL
- Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Minimize freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
PIK3CA alterations in Middle Eastern ovarian cancers." in: Molecular cancer, Vol. 8, pp. 51, (2009) (PubMed).
: "
-
PIK3CA alterations in Middle Eastern ovarian cancers." in: Molecular cancer, Vol. 8, pp. 51, (2009) (PubMed).
-
- Target
- PIK3CA (Phosphoinositide-3-Kinase, Catalytic, alpha Polypeptide (PIK3CA))
- Andere Bezeichnung
- PIK3CA (PIK3CA Produkte)
- Synonyme
- CLOVE antikoerper, CWS5 antikoerper, MCAP antikoerper, MCM antikoerper, MCMTC antikoerper, PI3K antikoerper, p110-alpha antikoerper, C-P3K antikoerper, PI3-kinase antikoerper, PI3K-alpha antikoerper, pi3-k antikoerper, pi3k antikoerper, AA414921 antikoerper, C530050K14 antikoerper, p50alpha antikoerper, p55alpha antikoerper, p85alpha antikoerper, 6330412C24Rik antikoerper, caPI3K antikoerper, p110 antikoerper, p110alpha antikoerper, phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha antikoerper, Phosphoinositide-3-kinase, catalytic, alpha polypeptide antikoerper, phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha antikoerper, phosphoinositide-3-kinase regulatory subunit 1 antikoerper, PIK3CA antikoerper, GL50803_14855 antikoerper, pik3ca antikoerper, Pik3ca antikoerper, Pik3r1 antikoerper
- Hintergrund
- PIK3CA, p110-alpha, phosphoinositide-3-kinase, catalytic, alpha polypeptide , MGC142161, MGC142163, PI3K, PI3-kinase p110 subunit alpha, PtdIns-3-kinase p110, phosphatidylinositol 3-kinase, catalytic, 110-KD, alpha, phosphatidylinositol 3-kinase, catalyti
- Gen-ID
- 5290, 18706, 170911
- NCBI Accession
- NP_006209
- Pathways
- PI3K-Akt Signalweg, RTK Signalweg, T-Zell Rezeptor Signalweg, AMPK Signaling, Interferon-gamma Pathway, TLR Signalweg, Fc-epsilon Rezeptor Signalübertragung, EGFR Signaling Pathway, Neurotrophin Signalübertragung, Inositol Metabolic Process, Hepatitis C, CXCR4-mediated Signaling Events, Signaling Events mediated by VEGFR1 and VEGFR2, Signaling of Hepatocyte Growth Factor Receptor, VEGFR1 Specific Signals, VEGF Signaling
-